Zobrazeno 1 - 10 of 966 pro vyhledávání: '"Petrillo L"'
1
Akademický článek
The effects of human-caused mortality on mammalian cooperative breeders: a synthesis.
Autor: Ausband DE; U.S. Geological Survey, Idaho Cooperative Fish and Wildlife Research Unit, University of Idaho, 875 Perimeter Drive, MS 1141, Moscow, 83844, Idaho, USA., Rebholz PF; U.S. Geological Survey, Idaho Cooperative Fish and Wildlife Research Unit, University of Idaho, 875 Perimeter Drive, MS 1141, Moscow, 83844, Idaho, USA.; Idaho Cooperative Fish and Wildlife Research Unit, University of Idaho, 875 Perimeter Drive, MS 1141, Moscow, 83844, Idaho, USA., Petrillo L; U.S. Geological Survey, Idaho Cooperative Fish and Wildlife Research Unit, University of Idaho, 875 Perimeter Drive, MS 1141, Moscow, 83844, Idaho, USA.; Idaho Cooperative Fish and Wildlife Research Unit, University of Idaho, 875 Perimeter Drive, MS 1141, Moscow, 83844, Idaho, USA.
Publikováno v: Biological reviews of the Cambridge Philosophical Society [Biol Rev Camb Philos Soc] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.
Zobrazit plný text záznamu
2
Akademický článek
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial Participants.
Autor: Durbin SM; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Lundquist DM; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Pelletier A; Statistician, Brigham and Women's Hospital, Boston, MA., Jimenez R; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA., Petrillo L; Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, MA., Kim J; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Lynch K; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Healy M; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Johnson A; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Ollila N; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Yalala V; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Malowitz B; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Kehlmann A; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Chevalier N; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Turbini V; Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston, MA., Bame V; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., Heldreth H; Statistician, Brigham and Women's Hospital, Boston, MA., Silva J; Cancer Center Protocol Office, Massachusetts General Hospital, Boston, MA., McIntyre C; Department of Nursing & Patient Care Services, Massachusetts General Hospital, Boston, MA., Juric D; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA., Nipp RD; University of Oklahoma Stephenson Cancer Center, Oklahoma City, OK.
Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Sep; Vol. 20 (9), pp. 1252-1262. Date of Electronic Publication: 2024 Jun 10.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Editorial & Opinion
Palliative Care for All? An Assessment of Racial and Ethnic Disparities Research With Solutions.
Autor: Collons D; Dana-Farber Cancer Institute (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Brigham and Women's Hospital (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Massachusetts General Hospital (L.P.), Boston, Massachusetts, USA; Dartmouth-Hitchcock Medical Center (N.D.), Lebanon, New Hampshire, USA; Dartmouth Cancer Center (N.D.), Lebanon, New Hampshire, USA. Electronic address: dcollons@gmail.com., Florez N; Dana-Farber Cancer Institute (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Brigham and Women's Hospital (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Massachusetts General Hospital (L.P.), Boston, Massachusetts, USA; Dartmouth-Hitchcock Medical Center (N.D.), Lebanon, New Hampshire, USA; Dartmouth Cancer Center (N.D.), Lebanon, New Hampshire, USA., Petrillo L; Dana-Farber Cancer Institute (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Brigham and Women's Hospital (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Massachusetts General Hospital (L.P.), Boston, Massachusetts, USA; Dartmouth-Hitchcock Medical Center (N.D.), Lebanon, New Hampshire, USA; Dartmouth Cancer Center (N.D.), Lebanon, New Hampshire, USA., Dhawan N; Dana-Farber Cancer Institute (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Brigham and Women's Hospital (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Massachusetts General Hospital (L.P.), Boston, Massachusetts, USA; Dartmouth-Hitchcock Medical Center (N.D.), Lebanon, New Hampshire, USA; Dartmouth Cancer Center (N.D.), Lebanon, New Hampshire, USA., Gray TF; Dana-Farber Cancer Institute (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Brigham and Women's Hospital (D.C., N.F., T.F.G.), Boston, Massachusetts, USA; Massachusetts General Hospital (L.P.), Boston, Massachusetts, USA; Dartmouth-Hitchcock Medical Center (N.D.), Lebanon, New Hampshire, USA; Dartmouth Cancer Center (N.D.), Lebanon, New Hampshire, USA.
Publikováno v: Journal of pain and symptom management [J Pain Symptom Manage] 2023 Oct; Vol. 66 (4), pp. e521-e523. Date of Electronic Publication: 2023 Jun 24.
Zobrazit plný text záznamu
6
The Functional Resonance Analysis Approach to Assess Performance Variability During Emergency Conditions
Autor: Luigi Ranieri, Antonella Petrillo, De Felice F, Petrillo L
Technological innovation has led to the development of increasingly efficient and complex industrial plants. To manage this complexity, it is necessary to define an integrated vision of the socio-technological system that includes: technological, hum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a0c9365edd0a625d7392c70e3ffc45
https://doi.org/10.20944/preprints202001.0088.v1
Zobrazit plný text záznamu
7
Akademický článek
P30.05 Perception of Palliative Care and Prognostic Awareness of Lung Cancer Treatment in an Oncogene-Driven Lung Cancer Community
Autor: Roy, U. Basu, Elkins, I., Petrillo, L., Jacobson, M., Feldman, J.
Publikováno v: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S395-S396
Zobrazit plný text záznamu
8
Akademický článek
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.
Autor: Vidula N; Massachusetts General Hospital Cancer Center, Boston, MA, United States. nvidula@mgh.harvard.edu., Greenberg S; Western Health, Melbourne, Victoria, Australia., Petrillo L; Massachusetts General Hospital, Division of Palliative Care, Boston, MA, United States., Hwang J; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Melisko M; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Goga A; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Moasser M; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Magbanua M; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Park JW; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States., Rugo HS; University of California San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center Precision Medicine Cancer Building, San Francisco, CA, United States.
Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2021 Sep 06; Vol. 7 (1), pp. 113. Date of Electronic Publication: 2021 Sep 06.
Zobrazit plný text záznamu
9
Akademický článek
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Autor: Zubiri L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Molina GE; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Mooradian MJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Cohen J; Division of Oncology, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Durbin SM; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Petrillo L; Division of Palliative Care, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Boland GM; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Juric D; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Thomas MF; Division of Gastroenterology, Department of Medicine, Mass General Center for Cancer Research, Division of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Faje AT; Neuroendocrine Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Rengarajan M; Division of Endocrinology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Guidon AC; Division of Neuromuscular Disorders, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Chen ST; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Okin D; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Medoff BD; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Nasrallah M; Division of Rheumatology, Allergy, Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kohler MJ; Division of Rheumatology, Allergy, Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Schoenfeld SR; Division of Rheumatology, Allergy, Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Karp-Leaf RS; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sise ME; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Neilan TG; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zlotoff DA; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Farmer JR; Division of Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Bardia A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sullivan RJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Blum SM; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Villani AC; Massachusetts General Hospital Center for Immunology and Inflammatory Diseases, Mass General Center for Cancer Research, Division of Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Reynolds KL; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA kreynolds7@partners.org.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Sep; Vol. 9 (9).
Zobrazit plný text záznamu
10
Akademický článek
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data.
Autor: Reynolds KL; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA kreynolds7@partners.org., Arora S; Office of Oncologic Diseases, US Food and Drug Administration, Silver Spring, Florida, USA., Elayavilli RK; Program Director, Project Data Sphere, Cary, North Carolina, USA., Louv WC; President, Project Data Sphere, Cary, North Carolina, USA., Schaller TH; Program Director, Project Data Sphere, Cary, North Carolina, USA., Khandelwal A; Global Head of Portfolio Strategy & Innovation, Merck KGaA, Darmstadt, Germany., Rothenberg M; Former Chief Medical Officer, Pfizer Inc, New York, New York, USA., Khozin S; Chief Executive Officer, ASCO CancerLinQ LLC, Alexandria, Virginia, USA., Guidon AC; Division of Neuromuscular Disorders, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Zubiri L; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Petrillo L; Division of Palliative Care, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Sise ME; Division of Nephrology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Villani AC; Center for Immunology and Inflammatory Diseases and Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Johnson DB; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Rahma O; Center for Immuno-Oncology and Gastroenterology Cancer Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sharon E; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje